{"product_id":"foundation-for-advanced-cardiovascular-education-and-training-dallas-cv-updates-2026","title":"Foundation for Advanced Cardiovascular Education and Training Dallas CV Updates 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: cardiologists, vascular surgeons, and electrophysiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe Dallas CV Updates 2026, hosted by the Foundation for Advanced Cardiovascular Education and Training (FACET), took place on February 21, 2026. The conference highlighted the latest advancements in cardiology, focusing on congestive heart failure, coronary artery disease, pulmonary hypertension, and structural heart issues.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eEvaluate and implement endovascular and surgical interventions for vascular conditions, including Thoracic Outlet Syndrome, Renal Artery Stenosis, and Chronic Limb-Threatening Ischemia.\u003c\/p\u003e\n\u003cp\u003eOptimize lipid management in Coronary Artery Disease using Lipoprotein A and Apolipoprotein B, and utilize advanced imaging like Coronary CTA and FFR.\u003c\/p\u003e\n\u003cp\u003eAssess the latest techniques in structural heart and valve interventions, including TAVR, mitral innovations (robotics\/transcatheter), and tricuspid advances.\u003c\/p\u003e\n\u003cp\u003eApply updated strategies for arrhythmia management, comparing pulse field ablation, hybrid surgical-catheter approaches, and device-detected AFib anticoagulation.\u003c\/p\u003e\n\u003cp\u003eIntegrate new heart failure trial data and evaluate the indications for advanced therapies, including Barostim and cardiac contractility modulation.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for cardiologists, vascular surgeons, and electrophysiologists who want updates on structural heart interventions, CAD, and arrhythmias.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 Thoracic Outlet Syndrome- A ‘Pressing’ Diagnosis to Consider in Upper Extremity Heaviness and Swelling with Strenuous Activity\u003c\/p\u003e\n\u003cp\u003e02 Renal Artery Stenosis When to Consider Endovascular Intervention\u003c\/p\u003e\n\u003cp\u003e03 Iliac Vein Compression To Stent or Not to Stent That is the Question\u003c\/p\u003e\n\u003cp\u003e04 Chronic Limb-Threatening Ischemia When Endovascular and Surgical Options Can’t Play…Can Deep Vein Arterialization Save the Day\u003c\/p\u003e\n\u003cp\u003e05 Role of Lipoprotein A and Apolipoprotein B in Management of Lipid Optimization in Patients with Coronary Artery Disease\u003c\/p\u003e\n\u003cp\u003e06 Invasive Assessment and Management of Microvascular Dysfunction in Patients with Angina and Normal or Non-Obstructive CAD\u003c\/p\u003e\n\u003cp\u003e07 Role of Coronary CTA and Coronary CTA FFR in the Diagnosis and Management of CAD\u003c\/p\u003e\n\u003cp\u003e08 Utilization of Minimally Invasive LIMA and Multi-Arterial Conduit Bypass Grafts in Coronary Artery Bypass Surgery\u003c\/p\u003e\n\u003cp\u003e09 Safer, Faster, But Is It Better Clinical Outcomes with Pulse Field Ablation for Atrial Fibrillation\u003c\/p\u003e\n\u003cp\u003e11 Smart Detection, Smarter Protection Anticoagulation for Device-Detected New Onset Atrial Fibrillation\u003c\/p\u003e\n\u003cp\u003e12 When the Heart Needs a Boost Understanding Cardiac Contractility Devices for Frontline Clinicians\u003c\/p\u003e\n\u003cp\u003e13 Management of Asymptomatic High-Burden PVCs The Case For and Against Catheter Ablation\u003c\/p\u003e\n\u003cp\u003e14 Rediscovering the Forgotten Valve Advances in Tricuspid Intervention\u003c\/p\u003e\n\u003cp\u003e15 Mitral Innovation Port Access, Robotics, and Transcatheter Breakthroughs\u003c\/p\u003e\n\u003cp\u003e16 The Quiet Threat Severe Aortic Stenosis Without Symptoms\u003c\/p\u003e\n\u003cp\u003e17 Presentation 1 HF Trial Data and Outcomes\u003c\/p\u003e\n\u003cp\u003e18 Presentation 2 When to Get Advanced Heart Failure Involved\u003c\/p\u003e\n\u003cp\u003e19 Presentation 3 Data for Barostim and Cardiac Contractility Modulation Therapy\u003c\/p\u003e\n\u003cp\u003e20 Presentation 4 When Advanced Therapy is Needed\u003c\/p\u003e\n\u003cp\u003e21 LIVE CASE CAD\u003c\/p\u003e\n\u003cp\u003e22 LIVE CASE STRUCTURAL HEART\u003c\/p\u003e\n\u003cp\u003eBonus Complex Structural Heart Disease- Advancing TAVR With Electrosurgery and SESAME Techniques\u003c\/p\u003e\n\u003cp\u003eBonus Persistent and Refractory AFib- When to Use Hybrid Epicardial-Endocardial Ablation\u003c\/p\u003e\n\u003cp\u003eBonus Vascular Disease Updates From Dallas CV 2026- Carotid Stenting, CLTI, and PE Innovations\u003c\/p\u003e\n\u003cp\u003eBonus Women’s Cardiovascular Disease Across the Lifespan- From Pregnancy Risk to Menopause Management\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405752619204,"sku":null,"price":26.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/medicalcoursespro.com\/products\/foundation-for-advanced-cardiovascular-education-and-training-dallas-cv-updates-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}